(stage III) colon cancer.1 w1 Subsequent studies have shown that fluorouracil with folinic acid confers similar benefit but is less toxic and takes six months of treatment rather than a year.2 3 w2 This treatment improves absolute survival by an average of 5-10% at five years, which ...
Colorectal cancer or colon cancer is cancer of the large intestine (colon), which is the final part of the digestive tract. Both colon cancer and rectal cancer can be referred to as colorectal or bow
Xu X, et al. Efficacy and safety of regorafenib and fruquintinib as third-line treatment for colorectal cancer: a narrative review. Transl Cancer Res 2022;11(1):276-287. doi: 10.21037/tcr-20-3539 Sun Q, et al. (2014) Discovery of fruquintinib, ...
New colon cancer treatment shows promise A new way to treat certain types of colon cancer has shown promising results. CBS News chief medical correspondent Dr. Jon LaPook explains.May 30, 2015 Twitter Facebook Email
Israeli hospital develops new treatment for rectal cancer, effectively eliminating the cancer in nearly two-thirds of patients and removing need for surgery in most others.
A new treatment regimen for patients with metastatic colon cancer appears to offer clinical benefit even when used after multiple other treatments have failed, say research physicians at Georgetown Lombardi Comprehensive Cancer Center, a part of Georgeto
Researchers at University of Utah's Huntsman Cancer Institute have discovered a new target for possible future colon cancer treatments – a molecule that is implicated in 85 percent of colon cancer cases.
A new, cutting-edge study from the University of Ottawa (uOttawa) has found vanoxerine, a drug initially developed for the treatment of cocaine addiction, could impede advanced colorectal cancer stem cells by essentially re-wiring critical gene networks.
University of Massachusetts Amherst food science researchers have pinpointed a set of enzymes involved in tumor growth that could be targeted to prevent or treat colon cancer.
serial SPECT/CT imaging was used to monitor treatment response and calculate radiation-absorbed doses to tumors. All the DOTA-PRIT-treated animals tolerated the treatment well, and all 9 assessed mice had no trace of cancer remaining upon microscopic examination. There was also no detectable radia...